Advertisement

Topics

Pulmonx Corp. Company Profile

06:21 EDT 25th June 2018 | BioPortfolio

Based in Redwood City, California, and Neuchâtel, Switzerland, Pulmonx is an interventional pulmonology company focused on developing life-changing, cost-effective technologies that improve the lives of patients suffering from lung disease worldwide. For more information, visit www.pulmonx.com.


News Articles [69 Associated News Articles listed on BioPortfolio]

Pulmonx Submits Premarket Approval (PMA) Application to U.S. ...

Zephyr EBVs are the Only Minimally-Invasive, Removable Devices for Emphysema with Validated Diagnostic Tool to Select Patients Likely to Benefit from Treatment Read more...

Korea Investment CORP Boosts Stake in Mylan

Korea Investment CORP grew its position in Mylan by 462.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 736,474 shar...

GTX Corp First Quarter 2018 Summary

Revenues increased 76%, Subscribers increased 79%, G&A decreased 17% LOS ANGELES, May 16, 2018 (GLOBE NEWSWIRE) -- GTX Corp. (OTCQB:GTXO), an IoT platform and leading provider of personal loc...

GTX Corp Announces New GPS Take-Along World Tracker for $89.00

LOS ANGELES, June 05, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB:GTXO), an IoT platform and global provider of GPS tracking and monitoring wearable and wandering assistive technology, announced toda...

GTX Corp and Veristride Presenting Biometric Insoles at CES 2018

LOS ANGELES, Jan. 04, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB:GTXO), an Internet of Things (IoT) solutions provider in the personal location, wearable and wandering assistive technology business...

Emblem Corp. Issues President’s Letter to Shareholders

TORONTO, March 20, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (EMC.WT) ("Emblem" or the "Corporation") provides a Letter to its Shareholders as follows: Spring is upon us, and Emblem is ...

Emblem Corp. Reports 2018 First Quarter Results

Strengthened team, new products, and key distribution partnerships driving demand NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, May 2...

Scythian Biosciences Announces Name Change to SOL Global Investments Corp.

TORONTO, June 05, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that the Compa...

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Feasibility of a Minimally Invasive Thoracoscopic Ultrasound for Localization of Pulmonary Nodules

The ex-vivo lung will be evaluated by XLTF-UC180 for localization of the tumor. The ultrasound probe will be put on the lung surface in several different directions to obtain the cross sec...

Companies [43 Associated Companies listed on BioPortfolio]

Pulmonx

Pulmonx, based in Redwood City, CA, is focused on developing and marketing minimally-invasive medical devices and technologies for the diagnosis and treatment of pulmonary disorde...

Pulmonx Corporation

Based in Redwood City, California, and Neuchâtel, Switzerland, Pulmonx is an interventional pulmonology company focused on developing life-changing, cost-effective technologies...

Pulmonx, Inc.

Based in Redwood City, California, and Neuchâtel, Switzerland, Pulmonx is an interventional pulmonology company focused on developing life-changing, cost-effective technologies...

Pulmonx Corp.

Based in Redwood City, California, and Neuchâtel, Switzerland, Pulmonx is an interventional pulmonology company focused on developing life-changing, cost-effective technologies...

ATLANTIS DRUG CORP

Nil

More Information about "Pulmonx Corp." on BioPortfolio

We have published hundreds of Pulmonx Corp. news stories on BioPortfolio along with dozens of Pulmonx Corp. Clinical Trials and PubMed Articles about Pulmonx Corp. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pulmonx Corp. Companies in our database. You can also find out about relevant Pulmonx Corp. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...


Corporate Database Quicklinks



Searches Linking to this Company Record